Detalhe da pesquisa
1.
STX-478, a Mutant-Selective, Allosteric PI3Kα Inhibitor Spares Metabolic Dysfunction and Improves Therapeutic Response in PI3Kα-Mutant Xenografts.
Cancer Discov
; 13(11): 2432-2447, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37623743
2.
The role of complement in the tumor microenvironment.
Fac Rev
; 10: 80, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35028645
3.
SARS-CoV-2 Exacerbates COVID-19 Pathology Through Activation of the Complement and Kinin Systems.
Front Immunol
; 12: 767347, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34804054